This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (482) Clinical Cancer Research (62)

Published on in Vol 11 , No 7 (2022) :July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/35565, first published .
Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)

Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)

Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)

Authors of this article:

Clémence Baudin 1 Author Orcid Image ;   Charlotte Lussey-Lepoutre 2, 3 Author Orcid Image ;   Alice Bressand 4 Author Orcid Image ;   Camille Buffet 5 Author Orcid Image ;   Fabrice Menegaux 5, 6 Author Orcid Image ;   Marine Soret 6, 7 Author Orcid Image ;   David Broggio 8 Author Orcid Image ;   Céline Bassinet 9 Author Orcid Image ;   Christelle Huet 9 Author Orcid Image ;   Gemma Armengol 10 Author Orcid Image ;   Laurence Leenhardt 5 Author Orcid Image ;   Marie-Odile Bernier 1 Author Orcid Image
Article Authors Cited by (2) Tweetations (5) Metrics

Journals

  1. Sunavala-Dossabhoy G, Petti S. Effect of recombinant human thyroid stimulating hormone on long-term salivary gland dysfunction in thyroid cancer patients treated with radioactive iodine. A systematic review. Oral Oncology 2023;136:106280 View
  2. Piciu D, Bran S, Moldovan M, Varvara S, Piciu A, Cuc S, Moisescu-Goia C, Barbus E, Mester A, Onisor F. Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis. Cancers 2023;15(9):2558 View